May. 28 at 2:08 PM
$CHUC WSJ today on flavored vape health concerns. The article confirms teen vaping dropped from 5.0M in 2019 to 1.6M in 2024, down 68%. The FDA's primary argument against flavored approvals is statistically weakening. The article also confirms the 2019 EVALI lung crisis was mainly THC-related (not nicotine vapes). An important distinction regulators & investors should understand.
But here's the most important line for CHUC investors: "States & local jurisdictions choosing to restrict flavored vapes is a way of getting a handle on a problem that the FDA hasn't been able to solve."
CHUC's IKE age-gating system IS the solution the FDA hasn't been able to solve. 0% underage activation in clinical trials. Biometric verification. Bluetooth pairing. Random check-ins. The FDA validated it as the pathway to flavored PMTA authorization on May 5.
Health concerns about vaping are real & legitimate. Age-gating addresses the most critical one, youth access, it's a game changer. Long
$CHUC $MO $BTI
